Omar Adwan: Rule of Three in Complete Blood Count
Omar Adwan, Medical Laboratory Technologist at Modawah Lab Center, shared a post on LinkedIn:
“Rule of Three in Complete Blood Count (CBC)
The Rule of Three is a simple quality check used to verify the consistency of Red Blood Cell (RBC), Hemoglobin (Hb), and Hematocrit (Hct) values in a CBC report.
This rule is most accurate when red blood cells are normocytic (normal size) and normochromic (normal hemoglobin content).
Rule of Three formulas
- Hemoglobin (Hb, g/dL) approximately equals RBC (×10⁶/µL) × 3
- Hematocrit (Hct, %) approximately equals Hemoglobin (Hb, g/dL) × 3
- Hematocrit (Hct, %) approximately equals RBC (×10⁶/µL) × 9
The Rule of Three may not be applicable in the following conditions:
Microcytic hypochromic anemia
- Iron deficiency anemia
- Thalassemia
Macrocytic anemia
- Vitamin B12 deficiency
- Folate deficiency
Cold agglutinin disease
- May cause falsely decreased RBC counts and increased MCV
Marked anisocytosis or poikilocytosis
Lipemia, hemolysis, or icterus
- May interfere with hemoglobin measurement
Purpose of the Rule of Three
- To assess the relationship and consistency among RBC, Hemoglobin (Hb), and Hematocrit (Hct) values.
If Hb and Hct values do not follow the Rule of Three, further investigation should be performed, including:
- Peripheral blood smear review
- Evaluation for RBC agglutination
- Instrument-related errors
- Sample dilution or other pre-analytical issues
The Rule of Three is not a diagnostic tool, but rather an internal quality check used to evaluate the validity of CBC results before reporting.
Therefore, the Rule of Three remains a valuable guideline used by Medical Technologists and Hematology professionals to assess the plausibility of CBC results before releasing patient reports.”
Other posts featuring Omar Adwan on Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience